Structural changes in the brain in depression and relationship to symptom recurrence

CNS Spectrums
J Douglas Bremner

Abstract

Depression is an important public health problem affecting about 15% of the general population; however, little is known about possible changes in the brain that might underlie the disorder. Neuroimaging has been a powerful tool to map actual changes in the brain structure of depressed patients that might be directly related to their symptoms of depression. Some imaging studies of brain structure have shown smaller hippocampal volume with the chronicity of depression correlating to a reduction in volume. Although the meaning of these findings is unclear, other studies have shown increased amygdala volume. Studies have found reductions in volume of the frontal cortex, with some studies showing specific reductions in subregions of the frontal cortex, including the orbitofrontal cortex. Findings of an increase in white matter lesions in elderly patients with depression have been replicated and correlated with late-onset depression, as well as impairments in social and cognitive function. These findings point to alterations in a circuit of brain regions hypothesized to include the frontal cortex, hippocampus, amygdala, striatum, and thalamus, that underlie symptoms of depression.

References

Jan 1, 1978·Journal of Computer Assisted Tomography·J BentsonG Wilson
Feb 1, 1976·Psychological Medicine·B J CarrollA A Sugerman
May 1, 1992·Archives of General Psychiatry·C B NemeroffN R Dunnick
Jul 1, 1992·Archives of General Psychiatry·K R KrishnanC B Nemeroff
Oct 1, 1991·Psychiatry Research·M M HusainK R Krishnan
Dec 1, 1991·Psychiatry Research·W M McDonaldD G Blazer
Jan 11, 1991·The Journal of Neuropsychiatry and Clinical Neurosciences·K R KrishnanE H Ellinwood
Feb 11, 1991·The Journal of Clinical Endocrinology and Metabolism·K R KrishnanC B Nemeroff
Oct 1, 1990·The American Journal of Psychiatry·O M WolkowitzD Pickar
Nov 1, 1989·Biological Psychiatry·V P RaoC B Nemeroff
May 1, 1986·Journal of Affective Disorders·C H KellnerR M Post
Mar 1, 1988·Biological Psychiatry·K R KrishnanC B Nemeroff
Aug 29, 1981·Lancet·G D Pearlson, A E Veroff
Feb 1, 1980·Journal of Computer Assisted Tomography·T OkunoY Nakano
Mar 1, 1984·Archives of General Psychiatry·D R RubinowP W Gold
Nov 1, 1993·The American Journal of Psychiatry·G S AlexopoulosT Kakuma
May 1, 1994·The American Journal of Psychiatry·E H AylwardG D Pearlson
May 1, 1993·Psychiatry Research·D A AxelsonK R Krishnan
Jan 1, 1993·Archives of General Psychiatry·C E CoffeyC E Spritzer
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y I ShelineM W Vannier
Aug 9, 1996·Science·R M Sapolsky
Mar 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·R J SteingardP Barnes
Jun 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·J T O'BrienB Tress
Sep 1, 1996·The American Journal of Psychiatry·B S GreenwaldM Patel
Oct 1, 1996·The American Journal of Psychiatry·I M LesserN G Berman
Feb 1, 1997·Biological Psychiatry·O M WolkowitzH Weingartner
Jan 1, 1997·Journal of Affective Disorders·J PantelM Friedlinger
Oct 1, 1996·The Journal of Neuropsychiatry and Clinical Neurosciences·D A CahnR Westlake
Apr 24, 1997·Nature·W C DrevetsM E Raichle

❮ Previous
Next ❯

Citations

Dec 14, 2004·Harvard Review of Psychiatry·Dost Ongür, Stephan Heckers
Dec 24, 2005·Bulletin of the Menninger Clinic·John S Graves
Jun 10, 2010·Journal of Psychopharmacology·David A SlatteryJohn F Cryan
May 2, 2012·Molecular Psychiatry·P J LucassenD N Abrous
Apr 28, 2012·Journal of Child and Adolescent Psychopharmacology·Mujeeb U ShadUma Rao
Sep 13, 2020·Journal of Personalized Medicine·James Douglas BremnerOmer T Inan
Apr 3, 2007·European Archives of Psychiatry and Clinical Neuroscience·Boldizsár Czéh, Paul J Lucassen
Jun 21, 2011·The International Journal of Neuropsychopharmacology·Nicoletta Galeotti, Carla Ghelardini
Nov 23, 2017·Frontiers in Neuroscience·Yuki HiguchiIshwar S Parhar
May 2, 2003·Annals of the New York Academy of Sciences·Amit Anand, Anantha Shekhar
Mar 4, 2010·Journal of Clinical and Experimental Neuropsychology·Lisa A DukeJason Schwartz
Jan 6, 2011·The International Journal of Neuropsychopharmacology·Danuta LisieckaThomas Frodl
Feb 9, 2020·Journal of Magnetic Resonance Imaging : JMRI·Abhinav SrinathRomuald Girard
Jan 22, 2009·Psychiatry and Clinical Neurosciences·Andrea Parolin JackowskiJoan Kaufman
Aug 21, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·J Douglas Bremner, Peter McCaffery
Dec 12, 2021·Nature Reviews. Neuroscience·Gerard SanacoraMaurizio Popoli

❮ Previous
Next ❯

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.